Zai Lab

Biotech company Zai Lab reported Wednesday that its loss narrowed 24.5% to $335 million last year.

FAST NEWS: Zai Lab’s loss narrows on strengthening sales

The latest: Biotech company Zai Lab Ltd. (9688.HK; ZLAB.US) reported Wednesday that its loss narrowed 24.5% to $335 million last year. Looking up: The narrower loss owed mainly to a 25% increase in revenue…
9688.HK ZLAB.US

Everest reaches new heights on growing drug sales

The innovative drug maker said its revenue soared more than 850% last year to between 124 million yuan and 126 million yuan Key Takeaways: Everest Medicines’ revenue soared nine-fold last…
1952.HK
Biotech company Zai Lab announced Wednesday that its loss narrowed 57% to $69.15 million in the third quarter from $161 million a year earlier.

FAST NEWS: Zai Lab’s loss narrows on growing revenue

The latest: Biotech company Zai Lab Ltd. (9688.HK; ZLAB.US) announced Wednesday that its loss narrowed 57% to $69.15 million in the third quarter from $161 million a year earlier. Looking up: The…
ZLAB.US 9688.HK

Recent Articles

RELATED ARTICLES

  1. Biotech company Zai Lab announced Wednesday that its loss narrowed 57% to $69.15 million in the third quarter from $161 million a year earlier.
    FAST NEWS: Zai Lab’s loss narrows on growing revenue
    ZLAB.US 9688.HK
  2. Joinn profits slide as lab monkey build-up backfires
    6127.HK 603127.SHG
  3. AstraZeneca pays hefty price for Chinese weight-loss drug
    AZN.US
  4. Everest reaches new heights on growing drug sales
    1952.HK
  5. CStone breaks up with drugs partner as U.S. rollout stalls
    2616.HK
  6. With no cure in sight, drugs firm LianBio begins exit strategy
    LIAN.US
  7. BeiGene goes for global growth with sales and R&D push
    BGNE.US 6160.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners